| Financial Year |
March 31 2023 |
| Monetary Funds |
239,818,757.74 |
| Held-for-trading Financial Assets |
50,161,298.01 |
| Notes Receivable |
33,416,567.34 |
| Accounts Receivable |
255,832,728.15 |
| Advances to Suppliers |
29,884,180.04 |
| Other Receivables |
6,468,116.04 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
157,405,681.71 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
8,629,819.91 |
| Total Current Assets |
805,727,033.25 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
85,110,277.98 |
| Investment Properties |
-- |
| Fixed Assetes |
218,668,104.20 |
| Under-construction Projects |
19,629,210.85 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
206,279.00 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
43,699,569.66 |
| R&D expenses |
-- |
| Goodwill |
435,260,324.85 |
| Long-Term Deferred and Prepaid Expenses |
3,583,696.74 |
| Deferred Income Tax Assets |
21,951,047.07 |
| Other Non-Current Assets |
9,501,806.55 |
| Sub-Total of Non-Current Assets |
918,192,547.21 |
| Total Assets |
1,723,919,580.46 |
| Short-Term Loans |
61,990,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
53,254,853.72 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,700,141.86 |
| Taxes Payable |
12,019,191.18 |
| Interest Payable |
-- |
| Dividend Payable |
2,367,035.59 |
| Other payables |
85,982,800.39 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
48,867,965.13 |
| Other Current Liabilities |
1,009,764.94 |
| Sub-Total of Current Liabilities |
286,001,109.05 |
| Long-term Loans |
148,636,307.38 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
837,146.46 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
151,805,860.37 |
| Total Liabilities |
437,806,969.42 |
| Paid-In Capital(Or Share Stock) |
289,057,018.00 |
| Capital Surplus |
369,186,234.13 |
| Surplus Reserve |
42,473,430.40 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
598,805,061.42 |
| Minority Stockholder's Interest |
12,082,282.13 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,274,030,328.91 |
| Owner's Equity（Stockholder's Equity） |
1,286,112,611.04 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,723,919,580.46 |
